Insights

Sustainable Palm Oil C16 Biosciences offers a sustainable, microbiology-based palm oil alternative that avoids deforestation and unethical labor practices. This creates a compelling value proposition for consumer goods, cosmetics, and food manufacturers seeking certified sustainable supply chains.

Commercial Readiness With recent launches like Palmless and a track record of venture and grant funding totaling over 34 million, C16 demonstrates progress toward scaling up production and commercialization, presenting an opportunity for strategic partnerships, pilot programs, and co-development deals.

Strategic Funding Strong investor interest from notable funders including the Bill & Melinda Gates Foundation signals credibility and potential for collaboration with mission-driven brands and large buyers seeking sustainable ingredients, potentially accelerating co-development and large-volume contracts.

Regulatory & Certification Position C16 to partner with certification bodies and regulators to obtain sustainability and risk credentials for their Palmless oil, enabling easier market access for food, cosmetics, and biofuel customers that require verifiable supply chain claims.

Industry Partnerships Target downstream players across food, personal care, and biofuel sectors that rely on palm oil or its alternatives. Propose joint development, price-stable supply agreements, and co-branding opportunities to differentiate buyers through sustainability story and reduced environmental risk.

C16 Biosciences Tech Stack

C16 Biosciences uses 8 technology products and services including MATLAB, iCIMS, html5media, and more. Explore C16 Biosciences's tech stack below.

  • MATLAB
    Advanced Analytics And Data Science
  • iCIMS
    Applicant Tracking Systems
  • html5media
    Audio, Video, Graphics
  • jsDelivr
    Content Delivery Network
  • Choices
    Javascript Libraries
  • Google Tag Manager
    Tag Management
  • Google Search Console
    Web Analytics
  • Adobe Fonts
    Web Fonts

Media & News

C16 Biosciences's Email Address Formats

C16 Biosciences uses at least 1 format(s):
C16 Biosciences Email FormatsExamplePercentage
First@c16bio.comJohn@c16bio.com
95%
F.Last@c16bio.comJ.Doe@c16bio.com
5%

Frequently Asked Questions

What is C16 Biosciences's official website and social media links?

Minus sign iconPlus sign icon
C16 Biosciences's official website is c16bio.com and has social profiles on LinkedInCrunchbase.

How much revenue does C16 Biosciences generate?

Minus sign iconPlus sign icon
As of July 2026, C16 Biosciences's annual revenue is estimated to be $10M - $25M.

What is C16 Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
C16 Biosciences's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does C16 Biosciences have currently?

Minus sign iconPlus sign icon
As of July 2026, C16 Biosciences has approximately 27 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Team Leader- Sr Scientist: V. Y.People Experience Specialist: I. C.Shareholder: J. A.. Explore C16 Biosciences's employee directory with LeadIQ.

What industry does C16 Biosciences belong to?

Minus sign iconPlus sign icon
C16 Biosciences operates in the Biotechnology Research industry.

What technology does C16 Biosciences use?

Minus sign iconPlus sign icon
C16 Biosciences's tech stack includes MATLABiCIMShtml5mediajsDelivrChoicesGoogle Tag ManagerGoogle Search ConsoleAdobe Fonts.

What is C16 Biosciences's email format?

Minus sign iconPlus sign icon
C16 Biosciences's email format typically follows the pattern of First@c16bio.com. Find more C16 Biosciences email formats with LeadIQ.

How much funding has C16 Biosciences raised to date?

Minus sign iconPlus sign icon
As of July 2026, C16 Biosciences has raised $34M in funding. The last funding round occurred on Jan 24, 2024 for $1M.

When was C16 Biosciences founded?

Minus sign iconPlus sign icon
C16 Biosciences was founded in 2018.
C16 Biosciences logo

C16 Biosciences

Biotechnology ResearchNew York, United States11-50 Employees

C16 Biosciences is a biotechnology research company headquartered in New York City at 619 West 54th Street, 7th Floor, New York, NY 10019. It develops sustainable alternatives to palm oil by brewing oils from microbes through fermentation. The company aims to reduce the environmental footprint of palm oil and provides opportunities for producers, refiners, traders, and consumers to invest in bio-based oils and sustainability efforts. C16 launched Palmless, an environmentally conscious palm oil alternative, with a first launch in 2023 and an expanded Palmless oil announced in 2025. The organization has a relatively small team, comprising 11 to 50 employees, and has attracted venture funding and investments from notable organizations.

Section iconCompany Overview

Website
c16bio.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $34M

    C16 Biosciences has raised a total of $34M of funding over 9 rounds. Their latest funding round was raised on Jan 24, 2024 in the amount of $1Mas a series_unknown.

  • $10M - $25M

    C16 Biosciences's revenue is estimated to be in the range of $10M - $25M

Section iconFunding & Financials

  • $34M

    C16 Biosciences has raised a total of $34M of funding over 9 rounds. Their latest funding round was raised on Jan 24, 2024 in the amount of $1Mas a series_unknown.

  • $10M - $25M

    C16 Biosciences's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.